Start Codon is a new model of life science and healthcare business accelerator, and the first in Cambridge, UK to provide companies with a combination of seed funding, facilities, mentoring and access to a dedicated team and network of industry leading contacts. The co-founders of Start Codon are Cambridge Innovation Capital, the Babraham Institute, Genentech (a member of the Roche Group), Dr Jonathan Milner and Dr Ian Tomlinson.

Launched in April 2019 to identify ideas that have the potential to impact the diagnosis, prevention and/or treatment of disease, and support their path to successful Series A funding, Start Codon aims to revolutionise the way life science and healthcare innovation is commercialised by reducing risk in investment opportunities and developing companies in the Cambridge, UK cluster that are built to succeed globally.

More from our Portfolio